GL1X · GenesisL1 explorer

MolNFT v1 · #186943 · protein

Structure of the SARS-cov-2 main protease in complex with inhibitor MPI13

7RVO · 3C-like proteinase: “Structure of the SARS-cov-2 main protease in complex with inhibitor MPI13”. X-ray diffraction, 1 ligand (7VI), 7 pockets (best druggability 0.76). MolNFT v1 #186943 on GenesisL1: 3D structure, binding sites and…

PDB
7RVO
Type
protein
Length
612 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
UniProt
P0DTD1
Ligands
7VI
Pockets
7 · best druggability 0.76

Structure

x-ray diffraction · 1 distinct chain · 25% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3C-like proteinaseprotein30625% helix, 29% strandP0DTD1

Ligands and binding sites

  • 7VI · N-[(benzyloxy)carbonyl]-L-valyl-3-cyclopropyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110200.760.7981empty
24320.620.7755empty
31980.520.78307VI
41800.480.76317VI
51550.440.7525empty

Interfaces

1 interface between chains.

  • A–B · 1712 Ų buried · 46 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7RVO · Structure of the SARS-CoV-2 main protease in complex with inhibitor MPI13 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.